FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149643192> ?p ?o ?g. }

• W2149643192 endingPage "661" @default.
• W2149643192 startingPage "654" @default.
• W2149643192 abstract "The nuclear factor-κB (NF-κB) signaling pathway has been targeted for therapeutic applications in a variety of human diseases, includuing cancer. Many naturally occurring substances, including curcumin, have been investigated for their actions on the NF-κB pathway because of their significant therapeutic potential and safety profile. A synthetic monoketone compound termed 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24) was developed from curcumin and exhibited potent anticancer activity. Here, we report a mechanism by which EF24 potently suppresses the NF-κB signaling pathway through direct action on IκB kinase (IKK). We demonstrate that 1) EF24 induces death of lung, breast, ovarian, and cervical cancer cells, with a potency about 10 times higher than that of curcumin; 2) EF24 rapidly blocks the nuclear translocation of NF-κB, with an IC₅₀ value of 1.3 μM compared with curcumin, with an IC₅₀ value of 13 μM; 3) EF24 effectively inhibits tumor necrosis factor (TNF)-α-induced IκB phosphorylation and degradation, suggesting a role of this compound in targeting IKK; and 4) EF24 indeed directly inhibits the catalytic activity of IKK in an in vitro-reconstituted system. Our study identifies IKK as an effective target for EF24 and provides a molecular explanation for a superior activity of EF24 over curcumin. The effective inhibition of TNF-α-induced NF-κB signaling by EF24 extends the therapeutic application of EF24 to other NF-κB-dependent diseases, including inflammatory diseases such as rheumatoid arthritis." @default.
• W2149643192 created "2016-06-24" @default.
• W2149643192 creator A5016747290 @default.
• W2149643192 creator A5017286737 @default.
• W2149643192 creator A5022570940 @default.
• W2149643192 creator A5022871106 @default.
• W2149643192 creator A5032077625 @default.
• W2149643192 creator A5041063201 @default.
• W2149643192 creator A5046819496 @default.
• W2149643192 creator A5059710197 @default.
• W2149643192 creator A5071096198 @default.
• W2149643192 creator A5072454821 @default.
• W2149643192 creator A5082310628 @default.
• W2149643192 creator A5087592679 @default.
• W2149643192 date "2008-06-24" @default.
• W2149643192 modified "2023-10-15" @default.
• W2149643192 title "Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin" @default.
• W2149643192 cites W1963549994 @default.
• W2149643192 cites W1963761369 @default.
• W2149643192 cites W1973528397 @default.
• W2149643192 cites W1976194786 @default.
• W2149643192 cites W1993570389 @default.
• W2149643192 cites W1998038367 @default.
• W2149643192 cites W2001970893 @default.
• W2149643192 cites W2004827880 @default.
• W2149643192 cites W2008872627 @default.
• W2149643192 cites W2012016116 @default.
• W2149643192 cites W2020374958 @default.
• W2149643192 cites W2027260180 @default.
• W2149643192 cites W2045811396 @default.
• W2149643192 cites W2055878807 @default.
• W2149643192 cites W2056533846 @default.
• W2149643192 cites W2065620962 @default.
• W2149643192 cites W2082575834 @default.
• W2149643192 cites W2092032160 @default.
• W2149643192 cites W2096685256 @default.
• W2149643192 cites W2102151538 @default.
• W2149643192 cites W2105896882 @default.
• W2149643192 cites W2109689528 @default.
• W2149643192 cites W2113662093 @default.
• W2149643192 cites W2136095930 @default.
• W2149643192 cites W2137138278 @default.
• W2149643192 cites W2159979956 @default.
• W2149643192 cites W2165269110 @default.
• W2149643192 cites W2229924112 @default.
• W2149643192 cites W4321258509 @default.
• W2149643192 cites W85545512 @default.
• W2149643192 doi "https://doi.org/10.1124/mol.108.046201" @default.
• W2149643192 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2638506" @default.
• W2149643192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18577686" @default.
• W2149643192 hasPublicationYear "2008" @default.
• W2149643192 type Work @default.
• W2149643192 sameAs 2149643192 @default.
• W2149643192 citedByCount "144" @default.
• W2149643192 countsByYear W21496431922012 @default.
• W2149643192 countsByYear W21496431922013 @default.
• W2149643192 countsByYear W21496431922014 @default.
• W2149643192 countsByYear W21496431922015 @default.
• W2149643192 countsByYear W21496431922016 @default.
• W2149643192 countsByYear W21496431922017 @default.
• W2149643192 countsByYear W21496431922018 @default.
• W2149643192 countsByYear W21496431922019 @default.
• W2149643192 countsByYear W21496431922020 @default.
• W2149643192 countsByYear W21496431922021 @default.
• W2149643192 countsByYear W21496431922022 @default.
• W2149643192 countsByYear W21496431922023 @default.
• W2149643192 crossrefType "journal-article" @default.
• W2149643192 hasAuthorship W2149643192A5016747290 @default.
• W2149643192 hasAuthorship W2149643192A5017286737 @default.
• W2149643192 hasAuthorship W2149643192A5022570940 @default.
• W2149643192 hasAuthorship W2149643192A5022871106 @default.
• W2149643192 hasAuthorship W2149643192A5032077625 @default.
• W2149643192 hasAuthorship W2149643192A5041063201 @default.
• W2149643192 hasAuthorship W2149643192A5046819496 @default.
• W2149643192 hasAuthorship W2149643192A5059710197 @default.
• W2149643192 hasAuthorship W2149643192A5071096198 @default.
• W2149643192 hasAuthorship W2149643192A5072454821 @default.
• W2149643192 hasAuthorship W2149643192A5082310628 @default.
• W2149643192 hasAuthorship W2149643192A5087592679 @default.
• W2149643192 hasBestOaLocation W21496431922 @default.
• W2149643192 hasConcept C100175707 @default.
• W2149643192 hasConcept C104317684 @default.
• W2149643192 hasConcept C123298856 @default.
• W2149643192 hasConcept C17991360 @default.
• W2149643192 hasConcept C184235292 @default.
• W2149643192 hasConcept C185592680 @default.
• W2149643192 hasConcept C203014093 @default.
• W2149643192 hasConcept C2777730290 @default.
• W2149643192 hasConcept C2778250585 @default.
• W2149643192 hasConcept C2779730028 @default.
• W2149643192 hasConcept C502942594 @default.
• W2149643192 hasConcept C55493867 @default.
• W2149643192 hasConcept C62478195 @default.
• W2149643192 hasConcept C86339819 @default.
• W2149643192 hasConcept C86803240 @default.
• W2149643192 hasConcept C98274493 @default.
• W2149643192 hasConceptScore W2149643192C100175707 @default.
• W2149643192 hasConceptScore W2149643192C104317684 @default.

• next